Asia-Pacific Offsite Sterilization Service Market, By Method (Ethylene Oxide Sterilization, Gamma Sterilization, Steam Sterilization, X-Ray Technology, Electron Beam Sterilization, Hydrogen Peroxide Sterilization, and Others), Service Type (Contract Based Service and Pay-Per-Use), Purchase Type (Group Purchase Organization and Individual), Industry Size (Large, Medium, and Small), End User (Hospitals, Specialty Clinics, Medical Device Companies, Pharmaceutical Companies, Ambulatory Centers, Food and Beverage Companies, Academic and Research Institutes, and Others) - Industry Trends and Forecast to 2031.
Asia-Pacific Offsite Sterilization Service Market Analysis and Size
In the dynamic environment of healthcare services within the Asia-Pacific region, the demand for offsite sterilization services has witnessed a significant surge. The offsite sterilization sector has emerged as a pivotal player in meeting these healthcare needs as countries across the Asia-Pacific continue to prioritize stringent sterilization standards. This market analysis aims to explore the trends, challenges, and opportunities within the Asia-Pacific offsite sterilization service sector, providing valuable insights for stakeholders seeking to navigate and thrive in this evolving environment.
Key drivers of the Asia-Pacific offsite sterilization service market include the growing prevalence of Hospital-Acquired Infections (HAIs), increasing demand for in-vitro tests and medical equipment, and the rising use of e-beam sterilization. However, the market faces challenges such as increasing awareness of the negative effects of ethylene oxide and poor infrastructure availability in developing countries.
Data Bridge Market Research analyzes that the Asia-Pacific offsite sterilization service market is expected to reach USD 642,873.82 thousand by 2031 from USD 361,172.73 thousand in 2023, growing at a CAGR of 7.6% in the forecast period of 2024 to 2031.
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Year
|
2022 (Customizable 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Thousand
|
|
Segments Covered
|
Method (Ethylene Oxide Sterilization, Gamma Sterilization, Steam Sterilization, X-Ray Technology, Electron Beam Sterilization, Hydrogen Peroxide Sterilization, and Others), Service Type (Contract Based Service and Pay-Per-Use), Purchase Type (Group Purchase Organization and Individual), Industry Size (Large, Medium, and Small), End User (Hospitals, Specialty Clinics, Medical Device Companies, Pharmaceutical Companies, Ambulatory Centers, Food and Beverage Companies, Academic and Research Institutes, and Others)
|
|
Countries Covered
|
China, Japan, India, South Korea, Australia, South East Asia, and Rest of Asia-Pacific
|
|
Market Players Covered
|
STERIS., STERITECH, STERILE SERVICES SINGAPORE, Sina Sterilgamma Sdn. Bhd, Medivest Sdn Bhd., Serial System Ltd., Agrosurg Irradiators (India) Pvt Ltd, Taisei Kako Co., Ltd., Microtrol Sterilisation Services Pvt Ltd., SHENZHEN KING MEDICAL PACKAGING STERILIZATION SERVICE CO., LTD., China Biotech Corporation, Stevimed., Mitsu Scientific, and cochinsterilisation among others
|
Market Definition
Sterilization is a physical or chemical process that destroys all forms of life, especially microorganisms, spores, and viruses. Precisely defined, it is the complete destruction of all microorganisms by a suitable chemical agent or by heat, either wet steam under pressure at 120°C (250°F) or more for at least 15 minutes or dry heat at 160 to 180°C (320°F to 360°F) for three hours. In short, it is a process that is used to remove all kinds of microorganisms, such as bacteria, viruses, fungi, and prions among others, which are present in any area, surface, or medication. They are usually destroyed by using chemicals such as glutaraldehyde, chlorine, formaldehyde, and others. They can also killed by intense radiation or high temperature. They are widely used in food, spacecraft, and medicine industry.
Asia-Pacific Offsite Sterilization Service Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Growing Prevalence of Hospital-Acquired Infections (HAIs)
Hospital-Acquired Infections (HAIs) are nosocomial infections that occur during a patient’s stay at hospitals and related facilities and are not observed at the time of admission. Over the years, they have become a major cause of morbidity and mortality worldwide. The most common bacteria associated with HAIs include C. difficile, MRSA, Klebsiella, E. coli, Enterococcus, and Pseudomonas species.
Hospitalized patients with weakened immune systems face heightened susceptibility to these infections. Prolonged hospitalization exposes individuals to potential pathogens, while invasive medical procedures and devices pose additional infection risks. The emergence of antibiotic-resistant strains, often linked to overuse or misuse, further complicates treatment. In the context of sterilization services, ensuring the thorough sterilization of medical devices used in diagnostic and therapeutic procedures is crucial to mitigate the risk of hospital-acquired infections (HAIs). In addition, addressing inadequate hand hygiene among healthcare workers and environmental contamination is vital for preventing the transmission of infections within hospital settings.
The rising geriatric population and the increasing incidence of chronic diseases result in increased hospitalization rates, which, in turn, increases the occurrence of HAIs. This boosts the demand for sterilization services of medical instruments and other devices in the market, thus driving market growth.
- Increasing Demand for In-Vitro Tests and Medical Equipment
In Vitro Diagnostics (IVD) are tests done on samples such as blood or tissue that have been taken from the human body. These can detect diseases or other conditions and can be used to monitor a person’s overall health to help cure, treat, or prevent diseases.
The escalating global prevalence of diseases such as HIV infections, malaria, and hepatitis is driving a surge in demand for in-vitro tests and various medical devices and equipment. This heightened demand extends to the sterilization services market, as the increasing need for these diagnostic tools necessitates rigorous sterilization processes to ensure the safety and effectiveness of the medical devices used in conducting in-vitro tests.
There is a rise in the sterilization of equipment worldwide as medical devices have become widely available for various diseases due to the rapid manufacturing of medical devices. Hence, the rising need for the sterilization of these equipment is a major factor driving the market growth.
Opportunity
- Increasing Technical Progress and Modernization in Medical Equipment
The rising awareness of the crucial need for robust infection prevention measures, coupled with advancements in medical equipment technology and an upsurge in chronic disease cases, has established a significant potential for the modernization of medical equipment. Within the context of the sterilization services market, the growing recognition of the importance of stringent infection control aligns with the demand for cutting-edge sterilization services. The sterilization services market is poised for growth as the medical field experiences increased technical progress and a push for modernization driven by the imperative to uphold the highest standards of cleanliness and safety in healthcare facilities.
Growing technical advancements are also beneficial for economic growth and the healthcare sector and are primarily fruitful as they significantly affect the development of better and more advanced sterilization techniques. Thus, the surge in technical progress and modernization in medical equipment is expected to provide greater opportunities for market growth.
Restraint/Challenge
- Concerns Regarding the Safety of Reprocessed Instruments
Healthcare providers reprocess reusable medical devices to save money and reduce waste. Examples of reusable medical devices include surgical forceps, endoscopes, and stethoscopes. However, there are concerns about the safety and performance of reprocessed devices.
Inadequate cleaning and sterilization of instruments can result in the retention of blood, tissue, and other biological debris in reusable devices, which increases the risk of Surgical-Site Infections (SSIs) in patients. The debris can allow microbes to survive the subsequent disinfection or sterilization process, which could then lead to HAIs.
Inadequate reprocessing can also result in other adverse patient outcomes, such as tissue irritation from residual reprocessing materials such as chemical disinfectants. These factors are limiting the acceptance of reprocessing among hospital administrators and physicians.
The utilization of reprocessed instruments in various healthcare settings raises concerns, particularly in hospitals and clinics. The hesitations surrounding the adoption of reprocessed instruments, fueled by the need to reconcile cost efficiency with an unwavering commitment to patient safety, pose a significant obstacle to the expected market growth. Overcoming these reservations requires a comprehensive strategy encompassing the enhancement of sterilization processes, alignment with regulatory standards, and the cultivation of confidence among healthcare professionals in the safety and efficacy of reprocessed instruments. Striking a balance between cost efficiency and patient safety remains crucial. Thus, it acts as a major restraining factor for market growth.
Recent Developments
- In November 2023, GE HealthCare and Masimo announced a joint agreement to integrate Masimo’s Signal Extraction Technology (SET) pulse oximetry into GE HealthCare's portrait mobile wireless and wearable patient monitoring solution. Portrait mobile is built on the Internet of Medical Things (IoMT) platform, which uses the latest cloud technology to provide a complete experience for continuous wearable monitoring. With Masimo SET integration, clinicians can use Masimo's clinically proven Measure-through Motion and Low Perfusion measurement oxygen saturation (SpO2) technology to non-invasively detect changes in patient condition and continuously monitor. This agreement helped the company to expand its product portfolio in the patient care monitoring segment
- In June 2023, Teleflex Incorporated, a leading global provider of medical technologies announced that it has signed two group purchase agreements with Premier, Inc. The new contracts, which came into force on 1 July 2023 allow Premier members to take advantage of special rates and terms at their discretion. Premier also has a national contract with Teleflex for offsite sterilization service products and supplies, a national contract for central venous access, a sole source for central venous access for AscenDrive, and sole source for central venous access for SURPASS. This group purchase agreement includes access to Arrowg+ard Blue Plus CVC and Arrow ErgoPack Complete Systems. This purchase agreement helped the company increase its product revenue
- In January 2023, Baxter International Inc., a leading global medical technology company, announced a comprehensive strategic action plan to improve operational efficiency and long-term performance, accelerate innovation, and create value for all stakeholders. These changes include a plan to create the company and its renal care and acute therapies business units into an independent, publicly traded company, a simplified business and manufacturing footprint to improve business performance, and other portfolios to improve Baxter’s capital structure, including a review of strategic options for the BioPharma Solutions (BPS) business
- In November 2021, Masimo announced the launch of Dual SET Pulse Oximetry for a highly versatile patient monitoring and connectivity hub. The first application of Dual SET oximetry is an important step forward in Masimo SET-guided Critical Congenital Heart Disease (CCHD) screening with CE marking. This launch helped the company expand its oximeter portfolio
Asia-Pacific Offsite Sterilization Service Market Scope
Asia-Pacific offsite sterilization service market is segmented into five notable segments based on method, service type, purchase type, industry size, and end user.
Method
- Ethylene Oxide Sterilization
- Gamma Sterilization
- Steam Sterilization
- X-ray Technology
- Electron Beam Sterilization
- Hydrogen Peroxide Sterilization
- Others
On the basis of method, the market is segmented into ethylene oxide sterilization, gamma sterilization, steam sterilization, x-ray technology, electron beam sterilization, hydrogen peroxide sterilization, and others.
Service Type
- Contract Based Service
- Pay-Per-Use
On the basis of service type, the market is segmented into contract based service and pay-per-use
Purchase Type
- Group Purchase Organization
- Individual
On the basis of purchase type, the market is segmented into group purchase organization and individual.
Industry Size
- Large
- Medium
- Small
On the basis of industry size, the market is segmented into large, medium, and small.
End User
- Hospitals
- Specialty Clinics
- Medical Device Companies
- Pharmaceutical Companies
- Ambulatory Centers
- Food and Beverage Companies
- Academic and Research Institutes
- Others
On the basis of end user, the market is segmented into hospitals, specialty clinics, medical device companies, pharmaceutical companies, ambulatory centers, food and beverage companies, academic and research institutes, and others.
Asia-Pacific Offsite Sterilization Service Market Regional Analysis/Insights
The Asia-Pacific offsite sterilization service market is analyzed and market size insights and trends are provided based on method, service type, purchase type, industry size, and end user as referenced above.
The countries covered in this market report are China, Japan, India, South Korea, Australia, South East Asia, and rest of Asia-Pacific.
China is expected to dominate the market due to the growing prevalence of Hospital-Acquired Infections (HAIs).
The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as downstream and upstream value chain analysis, technical trends, Porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Asia-Pacific Offsite Sterilization Service Market Share Analysis
The Asia-Pacific offsite sterilization service market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on the Asia-Pacific offsite sterilization service market.
Some of the major players operating in the Asia-Pacific offsite sterilization service market are STERIS., STERITECH, STERILE SERVICES SINGAPORE, Sina Sterilgamma Sdn. Bhd, Medivest Sdn Bhd., Serial System Ltd., Agrosurg Irradiators (India) Pvt Ltd, Taisei Kako Co., Ltd., Microtrol Sterilisation Services Pvt Ltd., SHENZHEN KING MEDICAL PACKAGING STERILIZATION SERVICE CO., LTD., China Biotech Corporation, Stevimed., Mitsu Scientific, and cochinsterilisation among others.
SKU-